Search research articles
Contact Us
Filters
Showing results (241-250 of 528) with videos related to
Page
of 53
Sort By:
JAMA Network Open
|
August 5, 2025
Racial Differences in Screening Eligibility by Breast Density After State-Level Insurance Expansion
Mattia A Mahmoud, Sarah Ehsan, Sara P Ginzberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic
Helen A Shih, Fergus J Couch, Katherine L Nathanson, et al.
Cancer Research
|
August 27, 2009
Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del
Arcangela De Nicolo, Emilio Parisini, Quan Zhong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2014
Correlation of somatic mutations and clinical outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenib
Melissa A Wilson, Fengmin Zhao, Richard Letrero, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
A Thiopurine-like Mutagenic Process Defines TGCT Subtypes
Kevin M Brown, Jun Zhong, Adriana Morales Miranda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2017
Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk
Anita Villani, Mary-Louise C Greer, Jennifer M Kalish, et al.
Plos One
|
March 26, 2013
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling
Brijal M Desai, Jessie Villanueva, Thierry-Thien K Nguyen, et al.
JAMA Network Open
|
December 15, 2025
Genomic Ascertainment of CHEK2-Related Cancer Predisposition
Sun Young Kim, Jung Kim, Mark Ramos, et al.
JCO Oncology Practice
|
July 18, 2024
Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic Adenocarcinoma
Kelsey S Lau-Min, Heather Symecko, Kelsey Spielman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing
Judith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
Page
of 53
Search research articles
Search
Showing results (241-250 of 528) with videos related to
Sort By:
Page
of 53
JAMA Network Open
|
August 5, 2025
Racial Differences in Screening Eligibility by Breast Density After State-Level Insurance Expansion
Mattia A Mahmoud, Sarah Ehsan, Sara P Ginzberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic
Helen A Shih, Fergus J Couch, Katherine L Nathanson, et al.
Cancer Research
|
August 27, 2009
Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del
Arcangela De Nicolo, Emilio Parisini, Quan Zhong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2014
Correlation of somatic mutations and clinical outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenib
Melissa A Wilson, Fengmin Zhao, Richard Letrero, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
A Thiopurine-like Mutagenic Process Defines TGCT Subtypes
Kevin M Brown, Jun Zhong, Adriana Morales Miranda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2017
Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk
Anita Villani, Mary-Louise C Greer, Jennifer M Kalish, et al.
Plos One
|
March 26, 2013
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling
Brijal M Desai, Jessie Villanueva, Thierry-Thien K Nguyen, et al.
JAMA Network Open
|
December 15, 2025
Genomic Ascertainment of CHEK2-Related Cancer Predisposition
Sun Young Kim, Jung Kim, Mark Ramos, et al.
JCO Oncology Practice
|
July 18, 2024
Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic Adenocarcinoma
Kelsey S Lau-Min, Heather Symecko, Kelsey Spielman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing
Judith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
Page
of 53